CMS Open Payments · Program Year 2024
Merz North America, Inc.
Merz North America, Inc. reported $3,640,334.42 across General Payments, Research, and Ownership to 14,831 physicians and teaching hospitals across 14,835 transactions.
- $3.6M Top quartile payer
- All-tracks total
- 14,835 Top 10% volume
- Transactions
- 14,831 Top 10% reach
- Recipients
- +$292.1K
- General Payments vs PY2023
Merz North America, Inc. reported $3,640,334.42 across all CMS Open Payments tracks (General + Research + Ownership) to 14,831 physicians and teaching hospitals in Program Year 2024 - ranking #323 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $3,500,616.30, averaging $245.45 per recipient.
How Merz North America, Inc.'s $3.6M all-tracks total breaks down
Merz North America, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
C
74/100
Total payments
F
44/100
Transaction volume
A
100/100
Physician reach
A
100/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer merz-north-america-inc Merz North America, Inc.
$3.6M · #323/1,925 · 0.0% industry · PY2024
- TOT $3.6M
- RANK #323
- SHARE 0.0%
- TXN 14,835
- RCP 14,831
- CAT 4
- GEN $3.5M
- ΔGEN +$292.1K
- TOP1 12.8%
- PY 2024
Volume peers
Nearest volume peer: Mannkind Corporation ($3.7M)
Merz North America, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Merz North America, Inc.'s CMS-reported General Payments increased by $292.1K (+9.1%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: MERZ NORTH AMERICA, INC.PY2023: MERZ NORTH AMERICA, INC.PY2024: MERZ NORTH AMERICA, INC.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $3,208,513.03
- PY2024
- $3,500,616.30
What the Data Shows for Merz North America, Inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Merz North America, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
401 transactions worth $2.0M make "Consulting Fee" the top general-payment category in the 4-category breakdown below, 57.6% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Consulting Fee" leads Merz North America, Inc.'s 4-category general-payment breakdown at $2.0M, 57.6% of the reported total.
Merz North America, Inc. reports 4 general-payment categories - the top three are Consulting Fee (57.6%), Food and Beverage (25.5%), and Travel and Lodging (16.7%). The remaining 1 category make up 0.1% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Merz North America, Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $2.0M | 401 | 57.6% |
| Food and Beverage | $893.8K | 13,427 | 25.5% |
| Travel and Lodging | $585.7K | 970 | 16.7% |
| Education | $3.2K | 33 | 0.1% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $997,783.46 (28.5%) of $3,500,616.30 in this company's General Payments records across 4,908 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Merz North America, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Ross Radusky
$448,755.24 across 15 reported transactions
- 2
Sabrina Guillen Fabi
$354,200.08 across 38 reported transactions
- 3
Jeremy B Green
$67,344.42 across 28 reported transactions
- 4
Jennifer Levine
$65,199.16 across 46 reported transactions
- 5
Gideon Pui Yuen Kwok
$62,284.56 across 26 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Merz North America, Inc. ranks #323 of 1,925 by total payments (top 17% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,455 of 1,838 by HHI (bottom 21% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Carl Zeiss Meditec Digital Innovations LLC : $167.7K total payments, HHI 311
- Meisinger USA, LLC : $46.0K total payments, HHI 310
- MedShape, Inc. : $1.2M total payments, HHI 309
- Garrison Dental Solutions : $162.0K total payments, HHI 308
- Ossio Inc : $357.9K total payments, HHI 307
- Sanara MedTech Inc. : $748.7K total payments, HHI 306
- Merz North America, Inc. (this company) : $3.5M total payments, HHI 306
- Silk Road Medical, Inc. : $2.8M total payments, HHI 303
- Balt USA, LLC : $457.3K total payments, HHI 303
- InspireMD Ltd : $11.0K total payments, HHI 302
- Synthes USA Products LLC : $235.8K total payments, HHI 302
- Paratek Pharmaceuticals, Inc. : $1.2M total payments, HHI 302
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Merz North America, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Merz North America, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Merz North America, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Gramercy Extremity Orthopedics LLC
Aurinia Pharma U.S., Inc.
M.A. Med Alliance S.A.
Adcura, Inc.
Ortho Development Corporation
Put this to use
Merz North America, Inc. ranks #323 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See where Merz North America, Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Merz North America, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.